Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Selina S. Hamill"'
Publikováno v:
Lasers in Surgery and Medicine. 52:586-589
Background and objectives Nanosecond Q-switched lasers have been used for the removal of traditional and cosmetic tattoos. Picosecond lasers utilize pulse durations of 10-12 and provide more efficient clearance of tattoos. Safe and effective removal
Publikováno v:
Dermatologic Surgery. 45:1728-1731
Publikováno v:
Seminars in Cutaneous Medicine and Surgery. 37:217-225
Melasma is a common, acquired, chronic cutaneous pigment disorder that is often difficult to treat and has a high recurrence rate. The goal of a melasma treatment regimen is to decrease pigment production and increase elimination. Topical tyrosinase
Publikováno v:
Lasers in Surgery and Medicine. 50:890-892
Background Conventional tattoo removal consists of single-pass treatments, spaced 7-8 weeks apart, for a total of 7-10 sessions. A major limiting factor of this procedure is the development of cavitation bubbles and vacuoles within the epidermis and
Publikováno v:
Lasers in Surgery and Medicine. 50:61-63
OBJECTIVES To evaluate the long-term efficacy of treating nasal telangiectasias with the TRASER device. METHODS Subjects from the TRASER efficacy analysis clinical trial were invited for a 1-year follow-up. Standardized photographs were taken to comp
Publikováno v:
Lasers in surgery and medicine. 51(1)
The topical transparent perfluorodecalin-infused (PFD) silicone patch has been demonstrated to reduce epidermal whitening produced in association with laser-assisted tattoo removal. This optical clearing agent has enabled multiple laser passes to be
Publikováno v:
Lasers in surgery and medicine. 50(9)
Conventional tattoo removal consists of single-pass treatments, spaced 7-8 weeks apart, for a total of 7-10 sessions. A major limiting factor of this procedure is the development of cavitation bubbles and vacuoles within the epidermis and dermis that
Publikováno v:
Lasers in surgery and medicine. 50(1)
To evaluate the long-term efficacy of treating nasal telangiectasias with the TRASER device.Subjects from the TRASER efficacy analysis clinical trial were invited for a 1-year follow-up. Standardized photographs were taken to compare to baseline. The